pharmacie et médicaments – Baisse des remises sur les médicaments génériques

This written question asks about potential reductions in rebates for generic medicines in France. It seeks clarification on the impact of these changes on the pharmaceutical market and patient access to affordable treatments. The question concerns pharmaceutical companies, healthcare providers, and patients. It aims to understand how proposed rebate adjustments might affect drug pricing and the availability of generic medications.